Logo image of GRFS

GRIFOLS SA-ADR (GRFS) Stock Fundamental Analysis

USA - NASDAQ:GRFS - US3984384087 - ADR

8.85 USD
+0.16 (+1.84%)
Last: 11/13/2025, 12:15:39 PM
Fundamental Rating

6

Taking everything into account, GRFS scores 6 out of 10 in our fundamental rating. GRFS was compared to 531 industry peers in the Biotechnology industry. While GRFS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. GRFS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year GRFS was profitable.
GRFS had a positive operating cash flow in the past year.
GRFS had positive earnings in each of the past 5 years.
In multiple years GRFS reported negative operating cash flow during the last 5 years.
GRFS Yearly Net Income VS EBIT VS OCF VS FCFGRFS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

1.2 Ratios

With an excellent Return On Assets value of 1.50%, GRFS belongs to the best of the industry, outperforming 89.45% of the companies in the same industry.
GRFS has a Return On Equity of 5.75%. This is amongst the best in the industry. GRFS outperforms 91.53% of its industry peers.
GRFS has a better Return On Invested Capital (4.79%) than 92.28% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GRFS is significantly below the industry average of 15.75%.
The last Return On Invested Capital (4.79%) for GRFS is above the 3 year average (2.90%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.5%
ROE 5.75%
ROIC 4.79%
ROA(3y)0.66%
ROA(5y)1.4%
ROE(3y)2.39%
ROE(5y)4.54%
ROIC(3y)2.9%
ROIC(5y)3.1%
GRFS Yearly ROA, ROE, ROICGRFS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 3.99%, GRFS belongs to the top of the industry, outperforming 90.21% of the companies in the same industry.
GRFS's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 17.80%, GRFS belongs to the best of the industry, outperforming 93.79% of the companies in the same industry.
In the last couple of years the Operating Margin of GRFS has declined.
GRFS has a Gross Margin of 39.37%. This is in the better half of the industry: GRFS outperforms 74.01% of its industry peers.
In the last couple of years the Gross Margin of GRFS has declined.
Industry RankSector Rank
OM 17.8%
PM (TTM) 3.99%
GM 39.37%
OM growth 3Y11.99%
OM growth 5Y-6.16%
PM growth 3Y-17.15%
PM growth 5Y-29.24%
GM growth 3Y-0.88%
GM growth 5Y-3.34%
GRFS Yearly Profit, Operating, Gross MarginsGRFS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

GRFS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GRFS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, GRFS has about the same amount of shares outstanding.
Compared to 1 year ago, GRFS has an improved debt to assets ratio.
GRFS Yearly Shares OutstandingGRFS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
GRFS Yearly Total Debt VS Total AssetsGRFS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

GRFS has an Altman-Z score of 1.31. This is a bad value and indicates that GRFS is not financially healthy and even has some risk of bankruptcy.
GRFS has a better Altman-Z score (1.31) than 64.03% of its industry peers.
The Debt to FCF ratio of GRFS is 12.89, which is on the high side as it means it would take GRFS, 12.89 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of GRFS (12.89) is better than 90.77% of its industry peers.
GRFS has a Debt/Equity ratio of 1.66. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.66, GRFS is not doing good in the industry: 80.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.66
Debt/FCF 12.89
Altman-Z 1.31
ROIC/WACC0.91
WACC5.28%
GRFS Yearly LT Debt VS Equity VS FCFGRFS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

GRFS has a Current Ratio of 2.64. This indicates that GRFS is financially healthy and has no problem in meeting its short term obligations.
GRFS has a worse Current ratio (2.64) than 67.98% of its industry peers.
A Quick Ratio of 0.95 indicates that GRFS may have some problems paying its short term obligations.
With a Quick ratio value of 0.95, GRFS is not doing good in the industry: 87.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 0.95
GRFS Yearly Current Assets VS Current LiabilitesGRFS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 109.19% over the past year.
GRFS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.99% yearly.
Looking at the last year, GRFS shows a quite strong growth in Revenue. The Revenue has grown by 9.32% in the last year.
The Revenue has been growing slightly by 7.18% on average over the past years.
EPS 1Y (TTM)109.19%
EPS 3Y-6.22%
EPS 5Y-23.99%
EPS Q2Q%750%
Revenue 1Y (TTM)9.32%
Revenue growth 3Y13.5%
Revenue growth 5Y7.18%
Sales Q2Q%102.26%

3.2 Future

Based on estimates for the next years, GRFS will show a very strong growth in Earnings Per Share. The EPS will grow by 23.62% on average per year.
Based on estimates for the next years, GRFS will show a small growth in Revenue. The Revenue will grow by 6.19% on average per year.
EPS Next Y44.31%
EPS Next 2Y35.34%
EPS Next 3Y31.39%
EPS Next 5Y23.62%
Revenue Next Year5.31%
Revenue Next 2Y5.66%
Revenue Next 3Y6.07%
Revenue Next 5Y6.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GRFS Yearly Revenue VS EstimatesGRFS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
GRFS Yearly EPS VS EstimatesGRFS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.35, which indicates a rather expensive current valuation of GRFS.
GRFS's Price/Earnings ratio is rather cheap when compared to the industry. GRFS is cheaper than 95.29% of the companies in the same industry.
GRFS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.50, the valuation of GRFS can be described as very cheap.
Based on the Price/Forward Earnings ratio, GRFS is valued cheaper than 98.68% of the companies in the same industry.
GRFS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.43.
Industry RankSector Rank
PE 17.35
Fwd PE 7.5
GRFS Price Earnings VS Forward Price EarningsGRFS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

97.93% of the companies in the same industry are more expensive than GRFS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, GRFS is valued cheaper than 99.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.48
EV/EBITDA 7.37
GRFS Per share dataGRFS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

GRFS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GRFS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as GRFS's earnings are expected to grow with 31.39% in the coming years.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y35.34%
EPS Next 3Y31.39%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.71%, GRFS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 89.80, GRFS pays a better dividend. On top of this GRFS pays more dividend than 99.25% of the companies listed in the same industry.
GRFS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 4.71%

5.2 History

The dividend of GRFS decreases each year by -66.87%.
GRFS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-66.87%
Div Incr Years0
Div Non Decr Years0
GRFS Yearly Dividends per shareGRFS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

DP0%
EPS Next 2Y35.34%
EPS Next 3Y31.39%
GRFS Yearly Income VS Free CF VS DividendGRFS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

GRIFOLS SA-ADR

NASDAQ:GRFS (11/13/2025, 12:15:39 PM)

8.85

+0.16 (+1.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04
Earnings (Next)02-24 2026-02-24/amc
Inst Owners30.45%
Inst Owner Change0.86%
Ins Owners6.36%
Ins Owner ChangeN/A
Market Cap6.02B
Revenue(TTM)7.45B
Net Income(TTM)297.45M
Analysts75
Price Target13.22 (49.38%)
Short Float %2.06%
Short Ratio10.95
Dividend
Industry RankSector Rank
Dividend Yield 4.71%
Yearly Dividend0
Dividend Growth(5Y)-66.87%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-12 2025-08-12 (0.173385)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.54%
PT rev (3m)-1.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.23%
EPS NY rev (3m)2.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 17.35
Fwd PE 7.5
P/S 0.7
P/FCF 7.48
P/OCF 4.71
P/B 1.01
P/tB N/A
EV/EBITDA 7.37
EPS(TTM)0.51
EY5.76%
EPS(NY)1.18
Fwd EY13.34%
FCF(TTM)1.18
FCFY13.37%
OCF(TTM)1.88
OCFY21.24%
SpS12.67
BVpS8.79
TBVpS-7.54
PEG (NY)0.39
PEG (5Y)N/A
Graham Number10.04
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 5.75%
ROCE 7.45%
ROIC 4.79%
ROICexc 5.02%
ROICexgc 11.58%
OM 17.8%
PM (TTM) 3.99%
GM 39.37%
FCFM 9.34%
ROA(3y)0.66%
ROA(5y)1.4%
ROE(3y)2.39%
ROE(5y)4.54%
ROIC(3y)2.9%
ROIC(5y)3.1%
ROICexc(3y)3.07%
ROICexc(5y)3.33%
ROICexgc(3y)6.89%
ROICexgc(5y)7.47%
ROCE(3y)4.51%
ROCE(5y)4.82%
ROICexgc growth 3Y11.6%
ROICexgc growth 5Y-8.62%
ROICexc growth 3Y14.21%
ROICexc growth 5Y-7.74%
OM growth 3Y11.99%
OM growth 5Y-6.16%
PM growth 3Y-17.15%
PM growth 5Y-29.24%
GM growth 3Y-0.88%
GM growth 5Y-3.34%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.66
Debt/FCF 12.89
Debt/EBITDA 4.86
Cap/Depr 93.6%
Cap/Sales 5.5%
Interest Coverage 2.5
Cash Conversion 62.7%
Profit Quality 233.89%
Current Ratio 2.64
Quick Ratio 0.95
Altman-Z 1.31
F-Score8
WACC5.28%
ROIC/WACC0.91
Cap/Depr(3y)62.1%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.39%
Cap/Sales(5y)3.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.19%
EPS 3Y-6.22%
EPS 5Y-23.99%
EPS Q2Q%750%
EPS Next Y44.31%
EPS Next 2Y35.34%
EPS Next 3Y31.39%
EPS Next 5Y23.62%
Revenue 1Y (TTM)9.32%
Revenue growth 3Y13.5%
Revenue growth 5Y7.18%
Sales Q2Q%102.26%
Revenue Next Year5.31%
Revenue Next 2Y5.66%
Revenue Next 3Y6.07%
Revenue Next 5Y6.19%
EBIT growth 1Y44.14%
EBIT growth 3Y27.11%
EBIT growth 5Y0.58%
EBIT Next Year47.43%
EBIT Next 3Y22.74%
EBIT Next 5Y16.88%
FCF growth 1Y239.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y883.42%
OCF growth 3YN/A
OCF growth 5YN/A

GRIFOLS SA-ADR / GRFS FAQ

Can you provide the ChartMill fundamental rating for GRIFOLS SA-ADR?

ChartMill assigns a fundamental rating of 6 / 10 to GRFS.


What is the valuation status for GRFS stock?

ChartMill assigns a valuation rating of 9 / 10 to GRIFOLS SA-ADR (GRFS). This can be considered as Undervalued.


What is the profitability of GRFS stock?

GRIFOLS SA-ADR (GRFS) has a profitability rating of 7 / 10.


Can you provide the expected EPS growth for GRFS stock?

The Earnings per Share (EPS) of GRIFOLS SA-ADR (GRFS) is expected to grow by 44.31% in the next year.


Can you provide the dividend sustainability for GRFS stock?

The dividend rating of GRIFOLS SA-ADR (GRFS) is 5 / 10 and the dividend payout ratio is 0%.